Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 67
Filtrar
1.
Ultrasound Obstet Gynecol ; 61(1): 109-113, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-35793228

RESUMO

OBJECTIVE: To describe the feasibility of an ultrasound-guided repositioning technique for partially expelled intrauterine devices (IUDs) without use of sedation. METHODS: This was a descriptive feasibility study of patients with a partially expelled IUD managed in our outpatient clinic from January 2016 to February 2020. The partially expelled IUDs (vertical arm extending partially or entirely through the cervical canal) were repositioned at the uterine fundus using Hartmann alligator forceps under ultrasound guidance. Paracervical or intracervical anesthesia and prophylactic antibiotics were not used. Data related to the procedure and 6-month follow-up were extracted from patient medical records. The primary outcome was the success rate of the repositioning procedure, defined as ultrasound confirmation of the entire IUD located above the internal os. Secondary outcomes included the retention and expulsion rates of the repositioned IUD at 6 months after the procedure and description of complications. RESULTS: We included data from 55 women with a partially expelled IUD (35 levonorgestrel IUDs and 20 copper IUDs) referred for repositioning. Ultrasound-guided repositioning of the IUD was successful in 51 (92.7%) cases, while the procedure was not completed in four patients due to pain. Of the 55 procedures, 48 (87.3%) were performed by obstetrics and gynecology trainees under the supervision of a senior specialist. Among the 51 successfully repositioned IUDs, nine (17.6%) were expelled within 6 months after the procedure and six patients were lost to follow-up. No uterine perforation or infection-related complications occurred within 6 months of the procedure. CONCLUSION: The ultrasound-guided repositioning technique appears to be a safe and feasible approach for partially expelled IUDs. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.


Assuntos
Dispositivos Intrauterinos , Feminino , Humanos , Gravidez , Estudos de Viabilidade , Ultrassonografia de Intervenção , Útero/diagnóstico por imagem
2.
O.F.I.L ; 32(1): 89-87, enero 2022. tab
Artigo em Português | IBECS | ID: ibc-205739

RESUMO

Objetivos: Identificar estratégias para melhorar conhecimentos, atitudes e práticas (CAP) sobre medidas de prevenção e controle da COVID-19 no mundo.Métodos: Foi realizada uma revisão sistemática de evidência quantitativa e qualitativa com busca nas bases de dados PubMed, LILACS e Scopus. A qualidade do relato e da metodologia dos estudos incluídos foi avaliada por meio da ferramenta do Joanna Briggs Institute.Resultados: De 2.196 registros identificados na busca, 12 estudos foram incluídos. A maioria avaliou estratégias educacionais (n=10), principalmente treinamentos baseados em simulação (n=6) para profissionais de saúde (n=9). Independente da estratégia ou público, todos os estudos identificaram melhorias em conhecimento (n=7), prática (n=7) e atitude (n=4). Entretanto, todos os estudos apresentaram pelo menos uma limitação de qualidade.Conclusões: Estratégias efetivas foram identificadas para melhorar CAP na prevenção e controle da COVID-19, especialmente para profissionais de saúde com treinamento baseado em simulação (baixa qualidade). (AU)


Objectives: To identify strategies to improve knowledge, attitude, and practice (KAP) about prevention and control measures of COVID-19 in the world.Method: A systematic review of quantitative and qualitative evidence was conducted, searching PubMed, LILACS and Scopus databases. Reporting and methodological quality of the included studies was assessed using the Joanna Briggs Institute tool.Results: Of 2,196 records identified in the search, 12 studies were included. Most studies evaluated educational strategies (n=10), mainly training based on simulation (n=6) for health professionals (n=9). Regardless of strategy or audience, all studies identified improvements in knowledge (n=7), practice (n=7), and attitude (n=4). However, all studies presented at least one quality limitation.Conclusions: Effective strategies have been identified to improve CAP in the prevention and control of COVID-19, especially aimed at healthcare professionals with simulation-based training (low quality). (AU)


Assuntos
Humanos , Saúde Pública , Educação em Saúde , Coronavirus , Infecções , Terapêutica
3.
Ultrasound Obstet Gynecol ; 50(3): 315-323, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28236310

RESUMO

OBJECTIVE: To assess the available evidence comparing effectiveness of ovarian stimulation (OS) using clomiphene citrate (CC) and/or letrozole (LTZ) to reduce follicle-stimulating hormone (FSH) consumption compared with standard OS. METHODS: We performed a systematic review and meta-analysis of randomized controlled trials that compared reproductive outcomes following in-vitro fertilization. We searched 11 electronic databases and hand-searched the reference lists of included studies and related reviews. We stratified the results, separating studies according to the oral agent used (CC or LTZ) and the characteristics of the included women (expected poor ovarian response or other women). When combining the results of the included studies, we assessed the relative risk (RR) for live birth, clinical pregnancy, miscarriage and cycle cancelation, the Peto odds ratio (OR) for ovarian hyperstimulation syndrome (OHSS) and mean difference (MD) for the number of oocytes retrieved and FSH consumption. RESULTS: A total of 22 studies were included in the review. Considering women with expected poor ovarian response, the available evidence suggested that using CC to reduce FSH consumption during OS provided similar rates of live birth (RR, 0.9 (95% CI, 0.6-1.2), moderate-quality evidence) and clinical pregnancy (RR, 1.0 (95% CI, 0.8-1.4), moderate-quality evidence); the use of LTZ did not cause a relevant change in the number of oocytes retrieved (MD, -0.4 (95% CI, -0.9 to 0.1), high-quality evidence). Considering the studies evaluating other women, the available evidence suggested that using CC to reduce FSH consumption during OS reduced the number of oocytes retrieved (MD, -4.6 (95% CI, -6.1 to -3.0), high-quality evidence) and risk of OHSS (Peto OR, 0.2 (95% CI, 0.1-0.3), moderate-quality evidence), while results were similar for rates of live birth (RR, 0.9 (95% CI, 0.7-1.1), moderate-quality evidence) and clinical pregnancy (RR, 1.0 (95% CI, 0.8-1.1), high-quality evidence). The quality of the evidence was low or very low for other outcomes. CONCLUSION: The use of CC to reduce FSH consumption in women with expected poor ovarian response has the advantage of providing similar reproductive outcomes with reduced costs. For the other women, the use of CC for reducing FSH consumption has the additional advantage of reducing OHSS, but also reduces the total number of oocytes retrieved. More studies are needed to evaluate the effect of LTZ for the same purpose. Future studies should focus on cumulative pregnancy per oocyte retrieval, patient dissatisfaction and agreement to repeat the cycle if not pregnant, which are important outcomes for clinical decisions. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.


Assuntos
Clomifeno/farmacologia , Transferência Embrionária , Fertilização in vitro , Hormônio Foliculoestimulante/metabolismo , Nitrilas/farmacologia , Indução da Ovulação/métodos , Triazóis/farmacologia , Feminino , Humanos , Letrozol , Gravidez , Resultado da Gravidez , Ensaios Clínicos Controlados Aleatórios como Assunto
4.
Chem Commun (Camb) ; 53(14): 2268-2271, 2017 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-28149992

RESUMO

Aggregation, red-NIR emission and light-up upon nucleic acid G-quadruplex binding have been investigated for a prototype core-extended naphthalene diimide, which is capable of fast cellular entry and nucleolar localization. Both high-level colocalization with an anti-G-quadruplex antibody and nucleolin displacement reveal that the compound targets and thus makes visible nuclear DNA G-quadruplexes.


Assuntos
Corantes Fluorescentes/química , Quadruplex G , Anticorpos/química , Anticorpos/imunologia , Núcleo Celular/genética , Núcleo Celular/metabolismo , Proteínas Cromossômicas não Histona/imunologia , Corantes Fluorescentes/metabolismo , Células HEK293 , Humanos , Imidas/química , Imidas/metabolismo , Microscopia Confocal , Naftalenos/química , Naftalenos/metabolismo , Espectrometria de Fluorescência
6.
Transgenic Res ; 18(2): 173-83, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18686007

RESUMO

We have produced human alpha1-antitrypsin (A1AT), a major therapeutic protein, in genetically engineered tobacco plastids. Four different expression vectors have been evaluated which encode A1AT under the control of various 5' and 3' plastid expression elements. The use of heterologous promoter and terminator sequences derived from the corn and soybean plastid genomes leads to simpler and predictable recombinant genome patterns, avoiding unwanted recombination products between introduced and resident tobacco sequences. High level expression of unglycosylated A1AT, representing up to 2% of total soluble proteins, has been measured in leaves of transgenic tobacco lines. Some heterogeneity in the recombinant A1AT is detected after 2D protein separation, but the chloroplast-made protease inhibitors are fully active and bind to porcine pancreatic elastase.


Assuntos
Cloroplastos/genética , Regulação da Expressão Gênica de Plantas , Nicotiana/genética , Plantas Geneticamente Modificadas , alfa 1-Antitripsina/biossíntese , alfa 1-Antitripsina/genética , Animais , Eletroforese em Gel Bidimensional , Técnicas Genéticas , Glicosilação , Humanos , Espectrometria de Massas , Elastase Pancreática/química , Plastídeos/química , Plastídeos/metabolismo , Estrutura Terciária de Proteína , Suínos , alfa 1-Antitripsina/química
7.
Ann Oncol ; 17 Suppl 5: v20-24, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16807457

RESUMO

BACKGROUND: While combination of gemcitabine with anti-topoisomerase poisons is routinely used in oncology, little is known on the biological interactions between these drugs. DESIGN: To understand the cellular basis for this association, we hypothesized an interaction of the two agents at the topoisomerase level. A real-time RT-PCR method was designed to quantify topoisomerase expression after treatment with gemcitabine (GEM) in two human colon adenocarcinoma cell lines. Efficacy of drugs as single agents and in combination was analyzed on the basis of their cytotoxic effects. RESULTS: We showed that a) gemcitabine induces expression of all major eukaryotic topoisomerases (I, II alpha and beta) at definite times after drug administration; b) cytotoxicity was more relevant when cells were treated with GEM and the topoisomerase poison within a short period of time. In particular synergistic effects were found when the anti-topoisomerase II agent was given 3 h after gemcitabine or when the anti-topoisomerase I drug was delivered 3 h before or after the antimetabolite. CONCLUSIONS: These findings help explaining the effectiveness of the combined therapy GEM/topoisomerase poisons and suggest a drug administration protocol for clinical treatment.


Assuntos
Adenocarcinoma/tratamento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Colorretais/tratamento farmacológico , Desoxicitidina/análogos & derivados , Inibidores Enzimáticos/administração & dosagem , Inibidores da Topoisomerase , Adenocarcinoma/genética , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Neoplasias Colorretais/genética , DNA Topoisomerases/genética , DNA Topoisomerases/metabolismo , Desoxicitidina/administração & dosagem , Desoxicitidina/farmacologia , Esquema de Medicação , Avaliação Pré-Clínica de Medicamentos , Interações Medicamentosas , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Células HT29 , Humanos , Resultado do Tratamento , Gencitabina
8.
Ann Oncol ; 17 Suppl 5: v25-28, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16807458

RESUMO

BACKGROUND: The pyrimidine antimetabolite Gemcitabine (G) (2',2'-difluorodeoxycytidine) is used against several malignancies G exerts its antitumour effect mainly by incorporation of its triphosphate metabolite (dFdCTP) into DNA. Subsequently, DNA polymerase adds one additional deoxynucleotide and DNA synthesis is interrupted. The nuclear enzymes topoisomerase I and II (TPs) are critical for DNA function and cell survival; they control, maintain and modify DNA topology during both replication and translation of genetic materials. These enzymes induce cuts in one or both strands of DNA, allowing strands to pass through the nick and then rejoining the nicked strand of DNA. Anti-topoisomerase (TPs-inhibitors) drugs exist and are largely used in chemotherapy, however, most often blindly of the cancer TPs status. AIM: To understand the best association between G and TPs-inhibitors, we studied: (a) Topoisomerases I, II alpha and II beta mRNA expression in Peripheral Mononuclear Blood Cells (PBMCs) of patients with solid tumor, after 1, 2, 3, 4, 5, 6 h after treatment with Gemcitabine (G); b) in vivo expression of TPs genes after administration of Gemcitabine (a topoisomerases up-regulating drug) combined with the TPs inhibitors drugs (TID) Topotecan (T) and Etoposide (E), added to the culture beneath 1 h after TPD treatment. TPs mRNA expression was measured by quantitative real-time RT-PCR in PBMCs. RESULTS: The administration of 1-h infused G is followed by a fast rise of TPs expression (P > 0.0001 Student's t test, paired data, each patient control of himself); TPs inhibitors, sequentially given after G, highly reduced the TPs rising (P > 0.0001). CONCLUSIONS: G induces a TPs increase. A rationale might be available for combination chemotherapy (G plus TPs inhibitors). The study is ongoing to enroll further patients.


Assuntos
Antígenos de Neoplasias/genética , DNA Topoisomerases Tipo II/genética , DNA Topoisomerases Tipo I/genética , Proteínas de Ligação a DNA/genética , Desoxicitidina/análogos & derivados , Neoplasias/tratamento farmacológico , Neoplasias/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos de Neoplasias/metabolismo , Antimetabólitos Antineoplásicos/administração & dosagem , Antimetabólitos Antineoplásicos/farmacologia , DNA Topoisomerases Tipo I/metabolismo , DNA Topoisomerases Tipo II/metabolismo , Proteínas de Ligação a DNA/antagonistas & inibidores , Proteínas de Ligação a DNA/metabolismo , Desoxicitidina/administração & dosagem , Desoxicitidina/farmacologia , Esquema de Medicação , Inibidores Enzimáticos/administração & dosagem , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Leucócitos Mononucleares/metabolismo , Pessoa de Meia-Idade , Neoplasias/metabolismo , RNA Mensageiro/metabolismo , Fatores de Tempo , Inibidores da Topoisomerase I , Inibidores da Topoisomerase II , Gencitabina
9.
Eur J Pharmacol ; 432(1): 99-105, 2001 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-11734193

RESUMO

The effect of endotoxin on glucuronidation and hepatobiliary transport of quinolone antimicrobial agents was investigated in rats using sparfloxacin and p-nitrophenyl glucuronide as model drugs. The biliary clearance experiments were performed 24 h after a single intraperitoneal injection of endotoxin (1 mg/kg). Endotoxin significantly delayed the disappearance of sparfloxacin from plasma and increased plasma concentration of its glucuronide after intravenous injection of sparfloxacin (10 mg/kg). Significant decreases in the systemic clearance of sparfloxacin and the biliary clearance of sparfloxacin and the glucuronide were observed. Endotoxin had no effect on in vitro glucuronidation activity using p-nitrophenol as a substrate. When p-nitrophenyl glucuronide (8 mg/kg) was administered in endotoxin-pretreated rats, significant decreases in the systemic clearance, biliary clearance and renal clearance of p-nitrophenyl glucuronide were observed. These findings suggest that endotoxin decreases the biliary excretion of sparfloxacin and its glucuronide probably due to impairment of their hepatobiliary transport systems and renal handling.


Assuntos
Anti-Infecciosos/farmacocinética , Ductos Biliares/efeitos dos fármacos , Endotoxinas/farmacologia , Fluoroquinolonas , Glucuronídeos/farmacocinética , Animais , Ductos Biliares/metabolismo , Transporte Biológico/efeitos dos fármacos , Glucuronídeos/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Taxa de Depuração Metabólica , Nitrofenóis/metabolismo , Nitrofenóis/urina , Ratos , Ratos Wistar , Especificidade por Substrato , Fatores de Tempo
10.
Clin Exp Pharmacol Physiol ; 27(12): 980-6, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11117234

RESUMO

1. Methotrexate (MTX), an anticancer drug, has been shown to induce acute injury in the small intestine. The present study was designed to investigate the in vivo absorptive function of the small intestine injured by MTX using an amino-beta-lactam antibiotic cephalexin (CEX). Time-dependent changes in diamine oxidase (DAO) and alkaline phosphatase (ALP) activity in the small intestine and histopathological findings were also measured in rats treated with MTX (20 mg/kg). 2. Most severe mucosal damage was observed 2 days after MTX treatment and the area under the plasma concentration-time curve of CEX (AUC(CEX)) following oral administration of 20 mg/kg tended to decrease. Thereafter, the AUC(CEX) increased significantly and the histopathological changes diminished within 5 days. 3. Both villus height and mucosal weight followed the same pattern, decreasing in the first 2 or 3 days following treatment, increasing on the 5th day and returning to control levels by the 10th day. Methotrexate-induced changes in the mucosal wet weight/whole intestinal weight ratio were significantly correlated with those of AUC(CEX), but did not correlate with mucosal DAO and ALP activity. 4. These findings provide evidence that the change in the total amount of CEX is an index of the active transport function, probably by intestinal peptide transporter (PEPT1), and is well reflected by histopathological changes in the intestinal mucosa induced by MTX. In addition, there is a possibility that this method could be applied in the clinical setting for diagnosis of intestinal status and absorptive function.


Assuntos
Antimetabólitos Antineoplásicos/efeitos adversos , Caderinas , Cefalexina/metabolismo , Cefalosporinas/metabolismo , Absorção Intestinal , Intestino Delgado/efeitos dos fármacos , Proteínas de Membrana Transportadoras , Metotrexato/efeitos adversos , Fosfatase Alcalina/metabolismo , Amina Oxidase (contendo Cobre)/metabolismo , Animais , Proteínas de Transporte/metabolismo , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/enzimologia , Mucosa Intestinal/patologia , Intestino Delgado/patologia , Masculino , Ratos , Ratos Wistar
11.
J Pediatr ; 137(5): 608-16, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11060524

RESUMO

OBJECTIVE: To compare treatment choices of neonatal physicians and nurses in 11 European countries for a hypothetical case of extreme prematurity (24 weeks' gestational age, birth weight of 560 g, Apgar score of 1 at 1 minute). STUDY DESIGN: An anonymous, self-administered questionnaire was completed by 1401 physicians (response rate, 89%) and 3425 nurses (response rate, 86%) from a large, representative sample of 143 European neonatal intensive care units. Italy, Spain, France, Germany, the Netherlands, Luxembourg, Great Britain, Sweden, Hungary, Estonia, and Lithuania participated. RESULTS: Most physicians in every country but the Netherlands would resuscitate this baby and start intensive care. On subsequent deterioration of clinical conditions caused by a severe intraventricular hemorrhage, attitudes diverge: most neonatologists in Germany, Italy, Estonia, and Hungary would favor continuation of intensive care, whereas in the other countries some form of limitation of treatment would be the preferred choice. Parental wishes appear to play a role especially in Great Britain and the Netherlands. Nurses are more prone than doctors to withhold resuscitation in the delivery room and to ask parental opinion regarding subsequent treatment choices. CONCLUSION: An extremely premature infant is regarded as viable by most physicians, whereas after deterioration of the clinical conditions decision-making patterns vary according to country. These findings have implications for the ethical debate surrounding treatment of infants of borderline viability and for the interpretation and comparison of international statistics.


Assuntos
Tomada de Decisões , Ética Médica , Doenças do Prematuro/terapia , Terapia Intensiva Neonatal , Padrões de Prática Médica , Ressuscitação , Adulto , Atitude , Europa (Continente) , Feminino , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Masculino , Pessoa de Meia-Idade , Enfermeiras e Enfermeiros/psicologia , Médicos/psicologia , Ressuscitação/psicologia , Inquéritos e Questionários
12.
Lancet ; 355(9221): 2112-8, 2000 Jun 17.
Artigo em Inglês | MEDLINE | ID: mdl-10902625

RESUMO

BACKGROUND: The ethical issue of foregoing life-sustaining treatment for newborn infants at high risk of death or severe disability is extensively debated, but there is little information on how physicians in different countries actually confront this issue to reach end-of-life decisions. The EURONIC project aimed to investigate practices as reported by physicians themselves. METHODS: The study recruited a large, representative sample of 122 neonatal intensive-care units (NICUs) by census (in Luxembourg, the Netherlands, and Sweden) or stratified random sampling (in France, Germany, the UK, Italy, and Spain) with an overall response rate of 86%. Physicians' practices of end-of-life decision-making were investigated through an anonymous, self-administered questionnaire. 1235 completed questionnaires were returned (response rate 89%). FINDINGS: In all countries, most physicians reported having been involved at least once in setting limits to intensive care because of incurable conditions (61-96%); smaller proportions reported such involvement because of a baby's poor neurological prognosis (46-90%). Practices such as continuation of current treatment without intensification and withholding of emergency manoeuvres were widespread, but withdrawal of mechanical ventilation was reported by variable proportions (28-90%). Only in France (73%) and the Netherlands (47%) was the administration of drugs with the aim of ending life reported with substantial frequency. Age, length of professional experience, and the importance of religion in the physician's life affected the likelihood of reporting of non-treatment decisions. INTERPRETATION: A vast majority of neonatologists in European NICUs have been involved in end-of-life limitation of treatments, but type of decision-making varies among countries. Culture-related and other country-specific factors are more relevant than characteristics of individual physicians or units in explaining such variability.


Assuntos
Atitude do Pessoal de Saúde , Tomada de Decisões , Ética Médica , Eutanásia Passiva/psicologia , Unidades de Terapia Intensiva Neonatal , Papel do Médico , Adulto , Europa (Continente) , Feminino , Humanos , Recém-Nascido , Modelos Logísticos , Masculino , Respiração Artificial , Inquéritos e Questionários
13.
Minerva Ginecol ; 52(7-8): 289-97, 2000.
Artigo em Italiano | MEDLINE | ID: mdl-11148851

RESUMO

BACKGROUND: There is a very wide range of genitourinary disorders which can follow vaginal birth, including slight and occasional problems as well as serious disorders which could affect a woman's social and sexual life, for example the effects of dyspareunia on a woman's sexual identity, social marginalization as an inevitable result of symptoms like urinary incontinence, urgency and fecal incontinence. The aim of this study was to identify elements which may be of use in understanding the pathogenetic mechanisms of these disorders. METHODS: Three weeks after birth 537 mothers underwent a clinical genitourinary evaluation including: collection of data regarding pregnancy development and birth, genitourinary history (urinary problem data collected in accordance with the proposal of the International Continence Society), an objective genitourinary examination with a PC-test and identification of possible antagonist abdominal-diaphragmatic muscular synergies, instrumental tests in cases of post-partum urinary incontinence. RESULTS: Maternal age at birth, parity, weight before pregnancy and at term, weight increase, gestational age, duration of the second stage of labour, development and characteristics of birth, perineal condition and neonatal weight were the variables considered as risk factors while genuine stress urinary incontinence, urge incontinence, frequency, urgency, dysuria and inability to interrupt urination were the disorders whose dependence on the various risk factors were to be studied. The analysis of the association of the various pairs of variables recorded both positive and negative correlations, whether the population taken was that of all puerperae or that of only primiparae. CONCLUSIONS: Maternal age at birth, parity and duration of the second stage of labour, even if not always separable from other co-existing risk conditions, are the main responsible risk factors in the pathogenesis of urination disorders in puerperium. These results once again confirm the fundamental role of birth in the pathogenesis of female pelvic statics anomalies and of the genitourinary disorders which are their most evident chemical demonstration.


Assuntos
Transtornos Puerperais/etiologia , Transtornos Urinários/etiologia , Adulto , Fatores Etários , Peso ao Nascer , Peso Corporal , Feminino , Idade Gestacional , Humanos , Segunda Fase do Trabalho de Parto , Paridade , Gravidez , Fatores de Risco
14.
Int J Infect Dis ; 4(3): 118-22, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11179913

RESUMO

OBJECTIVE: To evaluate the propensity of lincomycin and clindamycin to induce release of endotoxin, the authors investigated endotoxin release in Escherichia coli isolated from a patient who developed septic shock following lincomycin treatment. METHODS: Endotoxin release from the E. coli isolate exposed to lincomycin, clindamycin, and ceftazidime were determined in vitro and in vivo. RESULTS: In vitro, this E. coli released significantly larger amounts of endotoxin after exposure for 6 hours to lincomycin or clindamycin versus no antibiotic; however, endotoxin release with these antibiotics was significantly less than with ceftazidime. There was no significant difference in in vitro endotoxin release between small (8 mg/L) and large (0.5 minimum inhibitory concentration [MIC]) doses of these antibiotics, and 0.5 MICs of lincomycin and clindamycin were 1024 and 256 mg/L, respectively. These results were supported by scanning electron microscopic observations, which demonstrated that lincomycin, clindamycin, and ceftazidime induced formation of filamentous cells. In addition, plasma endotoxin concentrations after treatment for 4 hours with lincomycin, clindamycin, and ceftazidime (5 mg/kg) were at least 20-fold higher than with no antibiotic in an E. coli sepsis rat model. CONCLUSION: Results of this study suggest that the bacteriostatic antibiotics, lincomycin and clindamycin, induce endotoxin release in the treatment of E. coli infections.


Assuntos
Antibacterianos/efeitos adversos , Endotoxinas/metabolismo , Infecções por Escherichia coli/tratamento farmacológico , Escherichia coli/efeitos dos fármacos , Lincomicina/efeitos adversos , Sepse/tratamento farmacológico , Animais , Ceftazidima/efeitos adversos , Clindamicina/efeitos adversos , Escherichia coli/fisiologia , Infecções por Escherichia coli/microbiologia , Humanos , Masculino , Testes de Sensibilidade Microbiana , Microscopia Eletrônica de Varredura , Ratos , Ratos Wistar , Sepse/microbiologia
15.
Antimicrob Agents Chemother ; 43(11): 2697-701, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10543749

RESUMO

Klebsiella pneumoniae endotoxin has been found to decrease hepatic P450-mediated drug-metabolizing enzyme activity in a time-dependent manner. In this study, we investigated the role of nitric oxide (NO) in the decrease in hepatic drug-metabolizing enzyme activity caused by endotoxin in vivo. We measured in vivo pharmacokinetic parameters of antipyrine in rats treated with endotoxin and/or a selective inhibitor of inducible NO synthase (iNOS), S-methylisothiourea. Intraperitoneal injection of endotoxin (1 mg/kg of body weight) dramatically decreased the systemic clearance of antipyrine, reflecting reduced hepatic drug-metabolizing enzyme activity, and significantly increased the level of nitrite and nitrate (NOx) in the plasma. S-Methylisothiourea (10 mg/kg) reversed this decreasing antipyrine clearance and reduced the level of NOx in plasma. Repeated injections of an NO donor, (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (FK-409; 10 mg/kg), at a dose which maintained plasma NOx at the same levels as those caused by endotoxin injection, also decreased the systemic clearance of antipyrine. These findings suggest that the overproduction of NO observed in this animal model is at least partially responsible for the significant reduction in the hepatic drug-metabolizing enzyme activity that may happen in a gram-negative bacterial infection.


Assuntos
Anti-Inflamatórios não Esteroides/farmacocinética , Antipirina/farmacocinética , Endotoxinas/metabolismo , Klebsiella pneumoniae/metabolismo , Óxido Nítrico/fisiologia , Animais , Biotransformação , Sistema Enzimático do Citocromo P-450/metabolismo , Inibidores Enzimáticos/farmacologia , Isotiurônio/análogos & derivados , Isotiurônio/farmacologia , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Doadores de Óxido Nítrico/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico Sintase Tipo II , Nitrocompostos/farmacologia , Ratos , Ratos Wistar
16.
Antimicrob Agents Chemother ; 42(12): 3136-40, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9835504

RESUMO

There is evidence indicating that the carbapenem antibiotic panipenem decreases plasma concentrations of valproic acid (VPA) in epileptic patients during VPA therapy. The mechanism for panipenem-induced changes in the pharmacokinetics of VPA was investigated in rats with and without bile duct cannulation. The effect of panipenem on the pharmacokinetics of diclofenac, which undergoes extensive enterohepatic recirculation, was also examined. VPA (50 mg/kg of body weight) or diclofenac (10 mg/kg of body weight) was administered intravenously under the steady-state plasma panipenem concentration of 4 microgram/ml, which had been achieved by a constant infusion rate. Panipenem decreased the plasma VPA concentrations in rats without bile duct cannulation but did not change the volume of the initial space and protein binding of VPA. However, panipenem had no effect on the plasma VPA concentrations and the biliary excretion of VPA in rats with bile duct cannulation. The secondary increase in plasma diclofenac concentration observed in the absence of panipenem was diminished in the presence of panipenem. These findings suggest that panipenem decreases plasma VPA concentrations by suppressing its enterohepatic recirculation, probably due to a panipenem-induced decrease in the numbers of enteric bacteria.


Assuntos
Anticonvulsivantes/sangue , Tienamicinas/farmacologia , Ácido Valproico/sangue , Animais , Anti-Inflamatórios não Esteroides/farmacocinética , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/farmacocinética , Bile/metabolismo , Diclofenaco/farmacocinética , Injeções Intravenosas , Masculino , Ratos , Ratos Wistar , Ácido Valproico/administração & dosagem , Ácido Valproico/farmacocinética
17.
J Pharm Pharmacol ; 50(8): 871-9, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9751451

RESUMO

The time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic cytochrome P450-dependent drug-metabolizing capacity (cytochrome P450 and b5 content, activity of aminopyrine N-demethylase, p-nitroanisole O-demethylase, aniline hydroxylase and benzphetamine N-demethylase) and on the pharmacokinetics of antipyrine have been determined in rats. Measurement of enzyme activity and antipyrine (after intravenous injection of 20 mg kg(-1)) were performed 2, 24 and 96 h after a single intraperitoneal injection of endotoxin (1 mg kg(-1)) and after repeated doses (once daily for 4 days). The contribution of tumour necrosis factor alpha (TNFalpha) to the endotoxin-induced changes was also examined in rats pretreated with granulocyte colony-stimulating factor (G-CSF). The systemic clearance of antipyrine and the activity of hepatic cytochrome P450-dependent drug-metabolizing enzymes were dramatically reduced 24 h after a single injection of endotoxin, but had returned to control levels by 96h. The magnitudes of these decreases in these measurements after repeated doses of endotoxin were similar to those seen 24h after the single dose. The systemic clearance of antipyrine correlated significantly with cytochrome P450 content and aminopyrine N-demethylase activity. In histopathological experiments, moderate hypertrophy of Kupffer cells was observed, with no evidence of severe liver-tissue damage. G-CSF pretreatment suppressed the increased plasma concentrations of TNFalpha produced 2 h after single endotoxin injection, but did not eliminate the endotoxin-induced decrease in the systemic clearance of antipyrine, suggesting that TNFalpha is not the sole component responsible for the reduction of cytochrome P450-mediated drug-metabolizing enzyme activity. These results provide evidence that a single intraperitoneal injection of 1.0 mgkg(-1)K. pneumoniae endotoxin in rats reduces hepatic P450 and b5 levels, and reduces the activity of various cytochrome P450-mediated drug-metabolizing enzymes without causing severe liver-tissue damage. This suggests that the effect of endotoxin on hepatic cytochrome P450-mediated drug-metabolizing isozymes is non-selective.


Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Endotoxinas/farmacologia , Fator Estimulador de Colônias de Granulócitos/farmacologia , Klebsiella pneumoniae , Fígado/enzimologia , Fator de Necrose Tumoral alfa/metabolismo , Animais , Anti-Inflamatórios não Esteroides/farmacocinética , Antipirina/farmacocinética , Área Sob a Curva , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Fígado/efeitos dos fármacos , Masculino , Ratos , Ratos Wistar , Fatores de Tempo
18.
FEMS Immunol Med Microbiol ; 21(4): 297-302, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9753002

RESUMO

The carbapenem-induced endotoxin release was evaluated using experimental models of gram-negative bacterial sepsis in Wistar rats. Infections with Escherichia coli, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus vulgaris and Proteus mirabilis resulted in an increase of the plasma endotoxin concentration after treatment with ceftazidime and carbapenems including imipenem, panipenem, meropenem and biapenem. Except for P. aeruginosa, the plasma endotoxin concentrations after carbapenem treatment were significantly lower than those after ceftazidime treatment. It is noteworthy that treatment of P. aeruginosa sepsis with meropenem or biapenem induced significantly more endotoxin release than other carbapenems and the endotoxin concentrations induced by these carbapenems reached those of ceftazidime treatment. The plasma endotoxin concentrations appeared to correlate with the reduction of platelet counts and the elevation of both glutamic oxaloacetic transaminase and glutamic pyruvic transaminase values.


Assuntos
Toxinas Bacterianas/metabolismo , Carbapenêmicos/farmacologia , Endotoxinas/metabolismo , Enterobacteriaceae/metabolismo , Pseudomonas aeruginosa/metabolismo , Sepse/metabolismo , Animais , Modelos Animais de Doenças , Bactérias Gram-Negativas/metabolismo , Ratos , Ratos Wistar
19.
Antimicrob Agents Chemother ; 42(9): 2178-83, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9736531

RESUMO

We have recently reported that endotoxin (lipopolysaccharide [LPS]) derived from Klebsiella pneumoniae dramatically decreased the biliary excretion of the beta-lactam antibiotic cefoperazone (CPZ), which is primarily excreted into the bile via the anion transport system, in rats. The present study was designed to investigate the effect of human recombinant granulocyte colony-stimulating factor (G-CSF), which is reported to be beneficial in experimental models of inflammation, on the pharmacokinetics and biliary excretion of CPZ in rats. CPZ (20 mg/kg of body weight) was administered intravenously 2 h after the intravenous injection of LPS (250 microgram/kg). G-CSF was injected subcutaneously at 12 microgram/kg for 3 days and was administered intravenously at a final dose of 50 microgram/kg 1 h before LPS injection. Peripheral blood cell numbers were also measured. LPS dramatically decreased the systemic and biliary clearances of CPZ and the bile flow rate. Pretreatment with G-CSF enhanced these decreases induced by LPS. The total leukocyte numbers were increased in rats pretreated with G-CSF compared to the numbers in the controls, while the total leukocyte numbers were decreased (about 3,000 cells/microliter) by treatment with LPS. Pretreatment with G-CSF produces a deleterious effect against the LPS-induced decrease in biliary secretion of CPZ, and leukocytes play an important role in that mechanism.


Assuntos
Bile/metabolismo , Cefoperazona/metabolismo , Cefalosporinas/metabolismo , Fator Estimulador de Colônias de Granulócitos/farmacologia , Lipopolissacarídeos/farmacologia , Animais , Humanos , Masculino , Neutrófilos/fisiologia , Ratos , Ratos Wistar , Fator de Necrose Tumoral alfa/biossíntese
20.
Am J Pathol ; 151(2): 539-47, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9250166

RESUMO

The present work was designed to elucidate the in vivo role of complement in the proteinuria-associated tubulointerstitial injury. Rats were intravenously injected with puromycin aminonucleoside, and massive proteinuria was observed within 5 days. Prominent tubulointerstitial injury characterized by proximal tubular degeneration, tubular dilatation, and leukocyte infiltration were observed 7 days after injection. C3 and C5b-9 were observed in the luminal side of proximal tubular cells. Renal function, assessed by inulin and para-aminohippurate clearance, was significantly decreased. To-assess the role of complement in this model, rats were injected with either cobra venom factor or soluble recombinant human complement receptor type 1 starting at day 3. These manipulations significantly improved tubulointerstitial pathology and para-aminohippurate clearance without affecting the degree of proteinuria. Deposition of C3 and C5b-9 was not detected in the kidney of rats depleted of complement by cobra venom factor. In rats treated with soluble complement receptor, C3 was still detected in the tubules, but deposition of C5b-9 was not observed. Soluble complement receptor was detected at the site of C3 deposition and in the urine. These data strongly suggest that complement plays a pivotal role in proteinuria-associated tubulointerstitial injury and that systemic complement depletion or inhibition of complement in the tubular lumen may diminish the tubulointerstitial damage.


Assuntos
Antimetabólitos Antineoplásicos/toxicidade , Complemento C3/fisiologia , Complexo de Ataque à Membrana do Sistema Complemento/fisiologia , Túbulos Renais/patologia , Nefrose/fisiopatologia , Puromicina Aminonucleosídeo/toxicidade , Animais , Complemento C3/antagonistas & inibidores , Proteínas Inativadoras do Complemento/farmacologia , Complexo de Ataque à Membrana do Sistema Complemento/antagonistas & inibidores , Venenos Elapídicos/farmacologia , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Humanos , Túbulos Renais/efeitos dos fármacos , Túbulos Renais/fisiopatologia , Nefrose/induzido quimicamente , Nefrose/patologia , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...